An Israeli firm called MNDL Bio has raised $2 million to develop its AI-powered gene optimization platform.
By using precise, algorithm-based engineering instead of conventional trial-and-error techniques, the platform aims to improve recombinant DNA technology.
This strategy seeks to increase success rates in synthetic biology, reduce costs, and expedite research and development.
MNDL Bio is a Synthetic Biology startup that uses cutting-edge computational systems that optimize gene expression to lower food and biotech application production costs and times.
The invention of MNDL Bio aims to democratize gene engineering access and has the potential to revolutionize product development across several industries.
25 years of expertise in business development, marketing, and sales, with 10 years as CEO. CEO of foodtech business Yofix Probiotics (2018–2022). Managing Director of a Division of Chemovil Group (2015-2017). From 2012 to 2015, Carmit Candy Industries’ CEO – M. Sc. in Business Engineering, CRMT.TA
Professor and head of TAU’s Synthetic Biology and Computational Systems Lab. Eight degrees in total, including doctorates in computer science and medical sciences. Awards include the Chaim Sheba Medical Center in Tel-Hashomer, the Asi Shnidman Foundation, the Weizmann Institute of Science Koshland Fellowship, and the Juludan Research Prize.
An Israeli firm called ERAN MILLER MNDL Bio has raised $2 million to develop its AI-powered gene optimization technology.
By using precise, algorithm-based engineering instead of conventional trial-and-error techniques, the platform aims to improve recombinant DNA technology.
This strategy seeks to increase success rates in synthetic biology, reduce costs, and expedite research and development.
MNDL Bio is a Synthetic Biology startup that uses cutting-edge computational systems that optimize gene expression to lower food and biotech application production costs and times.
The invention of MNDL Bio aims to democratize gene engineering access and has the potential to revolutionize product development across several industries.
STEVE GRUN CEO and Co-Founder
25 years of expertise in business development, marketing, and sales, with 10 years as CEO. CEO of foodtech business Yofix Probiotics (2018–2022). Managing Director of a Division of Chemovil Group (2015-2017). From 2012 to 2015, Carmit Candy Industries’ CEO – M. Sc. in Business Engineering, CRMT.TA
PROF. TAMIR TULLER CSO and Co-Founder
the head of TAU’s Computational Systems and Synthetic Biology lab. Eight degrees in total, including doctorates in computer science and medical sciences. Awards include the Chaim Sheba Medical Center in Tel-Hashomer, the Asi Shnidman Foundation, the Weizmann Institute of Science Koshland Fellowship, and the Juludan Research Prize.
ERAN MILLER CBO and Co-founder
Ten years of worldwide business development in agri/food-tech businesses, fifteen years of expertise managing R&D projects globally and evaluating startups for strategic investments (head of Asia-Pacific Operations at Modu, R&D program manager and system integration at IDF). Electrical engineering BSc and MBA
